Mammographic density, response to hormones, and breast cancer risk

Journal of Clinical Oncology

Volumn 29, Issue 22, 2011, Pages 2985-2992

  Boyd, Norman F ^a   Melnichouk, Olga ^a   Martin, Lisa J ^a   Hislop, Greg ^d   Chiarelli, Anna M ^b   Yaffe, Martin J ^c   Minkin, Salomon ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b CANCER CARE ONTARIO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HORMONE RESPONSE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; BREAST; BREAST TUMOR; CANADA; COMPARATIVE STUDY; DRUG EFFECT; ESTROGEN THERAPY; MASS SCREENING; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM; PAGET NIPPLE DISEASE; PATHOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; RADIOGRAPHY; REPRODUCTIVE HISTORY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME;

ADULT; AGED; BREAST; BREAST NEOPLASMS; BRITISH COLUMBIA; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL, HORMONAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LINEAR MODELS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, HORMONE-DEPENDENT; ONTARIO; PATIENT SELECTION; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; PREMENOPAUSE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCTIVE HISTORY; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 80051606250     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.33.7964     Document Type: Article

References (27)

1. Johns PC, Yaffe MJ: X-ray characterisation of normal and neoplastic breast tissues. Phys Med Biol 32:675-695, 1987 (Pubitemid 17098978)
2. Wolfe JN: Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol 126:1130-1139, 1976
3. Wolfe JN: Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 37:2486-2492, 1976
4. Ursin G, Wu AH, Bernstein L, et al: Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 12:332-338, 2003 (Pubitemid 36427994)
5. Byrne C, Schairer C, Wolfe J, et al: Mammographic features and breast cancer risk: Effects with time, age, and menopause status. J Natl Cancer Inst 87:1622-1629, 1995
6. Boyd NF, Byng JW, Jong RA, et al: Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study. J Natl Cancer Inst 87:670-675, 1995
7. Wolfe JN, Saftlas AF, Salane M: Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: A case-control study. AJR Am J Roentgenol 148:1087-1092, 1987 (Pubitemid 17083062)
8. Byrne C, Schairer C, Brinton LA, et al: Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes Control 12:103-110, 2001 (Pubitemid 32165267)
9. Harvey JA, Bovbjerg VE: Quantitative assessment of mammographic breast density: Relationship with breast cancer risk. Radiology 230:29-41, 2004 (Pubitemid 37549780)
10. Boyd NF, Rommens JM, Vogt K, et al: Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798-808, 2005 (Pubitemid 41430721)
11. McCormack VA, dos Santos Silva I: Breast density and parenchymal patterns as markers of breast cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1159-1169, 2006
12. Boyd N, Martin L, Stone J, et al: A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 11:1048-1053, 2002 (Pubitemid 35192656)
13. Greendale GA, Reboussin BA, Sie A, et al: Effects of estrogen and estrogen-progestin on mammographic parenchymal density: Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med 130:262-269, 1999 (Pubitemid 29091853)
14. Cuzick J, Warwick J, Pinney E, et al: Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 96:621-628, 2004 (Pubitemid 38584986)
15. Miller AB, Baines CJ, To T, et al: Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 147:1459-1476, 1992 (Pubitemid 23008476)
16. Miller AB, Baines CJ, To T, et al: Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 147:1477-1594, 1992
17. Byng JW, Boyd NF, Fishell E, et al: The quantitative analysis of mammographic densities. Phys Med Biol 39:1629-1638, 1994 (Pubitemid 24306719)
18. Boyd NF, Guo H, Martin LJ, et al: Mammographic density and the risk and detection of breast cancer. N Engl J Med 356:227-236, 2007 (Pubitemid 46143226)
19. Maskarinec G, Pagano I, Lurie G, et al: A longitudinal investigation of mammographic density: The multiethnic cohort. Cancer Epidemiol Biomarkers Prev 15:732-739, 2006
20. Byrne C, Ursin G, Martin CF, et al: Change in mammographic density with estrogen and progestin therapy: A measure of breast cancer risk in the Women's Health Initiative. Presented at the 101st Annual Meeting of the American Association of Cancer Research 2010, Washington, DC, April 17-21, 2010 (abstr 5741)
21. Cuzick J, Warwick J, Pinney L, et al: Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: A nested case-control study. J Natl Cancer Inst 103:744-752, 2011
22. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 347:1713-1727, 1996
23. van Duijnhoven FJ, Peeters PH, Warren RM, et al: Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density. Cancer Epidemiol Biomarkers Prev 15:462-467, 2006
24. Roper RJ, Griffith JS, Lyttle CR, et al: Interacting quantitative trait loci control phenotypic variation in murine estradiol-regulated responses. Endocrinology 140:556-561, 1999 (Pubitemid 29058184)
25. Pollard JW: Genetic regulation of estrogen responsiveness. Endocrinology 140:553-555, 1999
26. Khan SA, Sachdeva A, Naim S, et al: The normal breast epithelium of women with breast cancer displays an aberrant response to estradiol. Cancer Epidemiol Biomarkers Prev 8:867-872, 1999 (Pubitemid 29508721)
27. Yu JC, Hsiung CN, Hsu HM, et al: Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development. Breast Cancer Res 13:R13, 2011